title: Exfoliative erythrodermia induced by pantoprazole.
authors.forename: M
authors.initials: M
authors.lastname: Sánchez-Borges
authors.forename: L
authors.initials: L
authors.lastname: González-Aveledo
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D000287:Administration, Topical; D000328:Adult; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D004110:Diltiazem / Q000008:administration & dosage; D004643:Emollients / Q000008:administration & dosage; D005260:Female; D005401:Fissure in Ano / Q000188:drug therapy; D005756:Gastritis / Q000188:drug therapy; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage; D000077402:Pantoprazole; D010276:Parasympatholytics / Q000008:administration & dosage; D011092:Polyethylene Glycols / Q000008:administration & dosage; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D012841:Simethicone / Q000008:administration & dosage; D012882:Skin Tests; D013501:Surface-Active Agents / Q000008:administration & dosage
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D002121:Calcium Channel Blockers; D004643:Emollients; D009025:Morpholines; D010276:Parasympatholytics; D054328:Proton Pump Inhibitors; D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D012841:Simethicone; D000077402:Pantoprazole; D004110:Diltiazem; C013199:pinaverium